outlook
Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion previously.
Peak volume
200+
First seen
2026-08-04
Last seen
2026-08-04
Days trending
1 / 1
Countries
1
Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion previously.